MetLife Investment Management’s Cognyte Software CGNT Stock Holding History
Bought
Maintained
Sold
Other funds holding CGNT
CI
SM
RC
ACM
EMG
CCMLC
MetLife Investment Management's CGNT Position: Q2 2021 in Review
MetLife Investment Management sold out of Cognyte Software (CGNT) in Q2 2021, closing a stake of 25,212 shares — an estimated $701K sold.
MetLife Investment Management first reported a position in CGNT in Q1 2021 and held it in 1 quarter. The position peaked at $701K in Q1 2021. 176 funds tracked by Wall St. Rank hold CGNT as of Q2 2021.
- MetLife Investment Management reported no remaining Cognyte Software position as of Q2 2021 after selling out during the quarter.
- MetLife Investment Management sold 25,212 Cognyte Software shares in Q2 2021, an estimated $701K.
- MetLife Investment Management first reported a position in Cognyte Software in Q1 2021 and held it in 1 quarter.
- MetLife Investment Management's Cognyte Software position peaked at $701K in Q1 2021.
- 176 funds tracked by Wall St. Rank held Cognyte Software as of Q2 2021.
Based on MetLife Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.